Genetic instability in the RAD51 and BRCA1 regions in breast cancer

Cellular and Molecular Biology Letters

Volumn 12, Issue 2, 2007, Pages 192-205

  Nowacka Zawisza, Maria ^a   Bryś, Magdalena ^a   Romanowicz Makowska, Hanna ^b   Kulig, Andrzej ^b   Krajewska, Wanda M ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

BRCA1; Breast cancer; Loss of heterozygosity (LOH); RAD51

Indexed keywords

BRCA1 PROTEIN; RAD51 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE DELETION; GENETIC ASSOCIATION; GENETIC STABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION;

EID: 34249098046     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-006-0063-x     Document Type: Article

References (67)

1. Nathanson, K.L. and Weber, B.L. "Other" breast cancer susceptibility genes: searching for more holy grail. Hum. Mol. Genet. 10 (2001) 715-720.
2. Welcsh, P.L. and King, M.C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum. Mol. Genet. 10 (2001) 705-713.
3. Auranen, A., Song, H., Waterfall, C., Dicioccio, R.A., Kuschel, B., Kjaer, S.K., Hogdall, E., Hogdall, C., Stratton, J., Whittemore, A.S., Easton, D.F., Ponder, B.A., Novik, K.L., Dunning, A.M., Gayther, S. and Pharoah, P.D. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int. J. Cancer 117 (2005) 611-618.
4. Cousineau, I., Abaji C. and Belmaaza, A. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis. Cancer Res. 65 (2005) 11384-11391.
5. Schmutte, C., Tombline, G., Rhiem, K., Sadoff, M.M., Schmutzler, R., von Deimling, A. and Fishel, R. Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH). Cancer Res. 59 (1999) 4564-4569.
6. Shinohara, A., Ogawa, H., Matsuda, Y., Ushio, N., Ikoe, K. and Ogawa, T. Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nature Genet. 4 (1993) 239-243.
7. Takahashi, E., Matsuda, Y., Hori, T., Yasuda, N., Tsuji, S., Mori, M., Yoshimura, Y., Yamamoto, A., Morita, T. and Matsushiro, A. Chromosome mapping of the human (RECA) and mouse (Reca) homologs of the yeast RAD51 and Escherichia coli recA genes to human (15q15.1) and mouse (2F1) chromosomes by direct R-banding fluorescence in situ hybridization. Genomics 19 (1994) 376-378.
8. Benson, F.E., Stasiak, A. and West S.C. Purification and characterization of the human Rad51 protein, an analogue of E. coli RecA. EMBO J. 13 (1994) 5764-5771.
9. Baumann, P., Benson, F.E. and West, S.C. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell 87 (1996) 757-766.
10. Gupta, R., Bazemore, L.R., Golub, E.I. and Radding, C.M. Activities of human recombination protein Rad51. Proc Natl. Acad. Sci. USA 94 (1997) 463-468.
11. Yamamoto, A., Taki, T., Yagi, H., Habu, T., Yoshida, K., Yoshimura, Y., Yamamoto, K., Matsushiro, A., Nishimune, Y. and Morita, T. Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells. Mol. Gen. Genet. 251 (1996) 1-12.
12. Chen, F., Nastasi, A., Shen, Z., Brenneman, M., Crissman, H. and Chen, D.J. Cell cycle-dependent protein expression of mammalian homologs of yeast DNA double-strand break repair genes Rad51 and Rad52. Mutat. Res. 384 (1997) 205-211.
13. Xia, S.J., Shammas, M.A. and Shmookler Reis, R.J. Elevated recombination in immortal human cells is mediated by HsRAD51 recombinase. Mol. Cell. Biol. 17 (1997) 7151-7158.
14. Shen, Z., Cloud, K.G., Chen, D.J. and Park, M.S. Specific interactions between the human RAD51 and RAD52 proteins. J. Biol. Chem. 271 (1996) 148-152.
15. Sturzbecher, H.W., Donzelmann, B., Henning, W., Knippschild, U. and Buchhop, S. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J. 15 (1996) 1992-2002.
16. Buchhop, S., Gibson, M.K., Wang, X.W., Wagner, P., Sturzbecher, H.W. and Harris, C.C. Interaction of p53 with the human Rad51 protein. Nucleic Acids Res. 25 (1997) 3868-3874.
17. Wong, A.K., Pero, R., Ormonde, P.A., Tavtigian, S.V. and Bartel, P.L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 272 (1997) 31941-31944.
18. Marmorstein, L.Y., Ouchi, T. and Aaronson, S.A. The BRCA2 gene product functionally interacts with p53 and RAD51. Proc. Natl. Acad. Sci. USA. 95 (1998) 13869-13874.
19. Scully, R. Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T. and Livingston, D.M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 188 (1997) 265-275.
20. Zhong, Q., Chen, C.F., Li, S., Chen, Y., Wang, C.C., Xiao, J., Chen, P.L., Sharp, Z.D. and Lee, W.H. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285 (1999) 747-750.
21. Hall, J.M., Lee, M.K., Newman, B., Morrow, J.E., Anderson, L.A., Huey, B. and King, M.C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250 (1990) 1684-1689.
22. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W. Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P.K., Norris, F.H. Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J.C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., Skolnick, M.H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71.
23. Monteiro, A.N., August, A. and Hanafusa, H. Evidence for a trans-criptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA 93 (1996) 13595-13599.
24. Huyton, T., Bates, P.A., Zhang, X., Sternberg, M.J. and Freemont, P.S. The BRCA1 C-terminal domain: structure and function. Mutat. Res. 460 (2000) 319-332.
25. Koonin, E.V., Altschul, S.F. and Bork, P. BRCA1 protein products ... Functional motifs... . Nat. Genet. 13 (1996) 266-268.
26. Bork, P., Hofmann, K., Bucher, P., Neuwald, A.F., Altschul, S.F.and Koonin, E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11 (1997) 68-76.
27. Larson, J.S., Tonkinson, J.L. and Lai, M.T. A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells. Cancer Res. 57 (1997) 3351-3355.
28. Moynahan, M.E., Chiu, J.W., Koller, B.H. and Jasin, M. Brca1 controls homology-directed DNA repair. Mol. Cell 4 (1999) 511-518.
29. Scully, R. and Livingston, D.M. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408 (2000) 429-432.
30. Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S.J. and Qin, J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14 (2000) 927-939.
31. Cantor, S.B., Bell, D.W., Ganesan, S., Kass, E.M., Drapkin, R., Grossman, S., Wahrer, D.C., Sgroi, D.C., Lane, W.S., Haber, D.A. and Livingston, D.M. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105 (2001) 149-160.
32. Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M.S., Timmers, C., Hejna, J., Grompe, M. and D'Andrea, A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 (2001) 249-262.
33. Franchitto, A. and Pichierri, P. Bloom's syndrome protein is required for correct relocalization of RAD50/MRE11/NBS1 complex after replication fork arrest. J. Cell Biol. 157 (2002) 19-30.
34. Liu, Y. and West, S.C. Distinct functions of BRCA1 and BRCA2 in doublestrand break repair. Breast Cancer Res. 4 (2002) 9-13.
35. Manke, I.A., Lowery, D.M., Nguyen, A. and Yaffe, M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302 (2003) 636-639.
36. Yu, X., Chini, C.C., He, M., Mer, G. and Chen, J. The BRCT domain is a phospho-protein binding domain. Science 302 (2003) 639-642.
37. Beckmann, M.W., Schnurch, H.G., Bodden-Heidrich, R., Mosny, D.S., Crombach, G., Nitz, U., Achnoula, M. and Bender, H.G. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines. Eur. J. Cancer Prev. 5 (1996) 468-475.
38. Hanby, A.M., Kelsell, D.P., Potts, H.W., Gillett, C.E., Bishop, D.T., Spurr, N.K. and Barnes, D.M. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer. Int. J. Cancer 88 (2000) 204-208.
39. Wright, D.K. and Manson, M.M. Sample preparation from paraffinembedded tissues. in: PCR Protocols: A Guide to Methods and Application, (Innis, M.A., Ed.), Academic Press, Inc., 1990, 153-156.
40. Rolfs, A., Schuller, I., Finckh, U. and Weber-Rolfs, J. PCR: clinical diagnostic and research. Springer Lab., 1992, 81-84.
41. Cawkwell, L., Bell, S.M., Lewis, F.A., Dixon, M.F., Taylor, G.R. and Quirke, P. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br. J. Cancer 67 (1993) 1262-1267.
42. Simpson, A.J. The natural somatic mutation frequency and human carcinogenesis. Adv. Cancer Res. 71 (1997) 209-240.
43. Thiagalingam, S., Foy, R.L., Cheng, K., Lee, H.J., Thiagalingam, A. and Ponte, J.F. Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr. Opin. Oncol. 14 (2002) 65-72.
44. Chen, J.J., Silver, D., Cantor, S., Livingston, D.M. and Scully, R. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Cancer Res. 59 (1999) 1752s-1756s.
45. Dasika, G.K., Lin, S.C., Zhao, S,, Sung, P., Tomkinson, A. and Lee, E,Y. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 18 (1999) 7883-7899.
46. Wang, W.W., Spurdle, A.B., Kolachana, P., Bove, B., Modan, B., Ebbers, S.M., Suthers, G., Tucker, M.A., Kaufman, D.J., Doody, M.M., Tarone, R.E., Daly, M., Levavi, H., Pierce, H., Chetrit, A., Yechezkel, G.H., Chenevix-Trench, G., Offit, K., Godwin, A.K. and Struewing, J.P. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 955-960.
47. Levy-Lahad. E, Lahad, A., Eisenberg, S., Dagan, E., Paperna, T., Kasinetz, L., Catane, R., Kaufman, B., Beller, U., Renbaum, P. and Gershoni-Baruch, R. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc. Natl. Acad. Sci. USA. 98 (2001) 3232-3236.
48. Goode, E.L., Dunning, A.M., Kuschel, B., Healey, C.S., Day, N.E., Ponder, B.A., Easton, D.F. and Pharoah, P.P. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res. 62 (2002) 3052-3057.
49. Błasiak, J., Przybyłowska, K., Czechowska, A., Zadrożny, M., Pertyński, T., Rykała, J., Koł acińska, A., Morawiec, Z. and Drzewoski, J. Analysis of the G/C polymorphism in the 5′-untranslated region of the RAD51 gene in breast cancer. Acta Biochim. Pol. 50 (2003) 249-253.
50. Romanowicz-Makowska, H., Smolarz, B. and Kulig, A. Germline BRCA1 mutations and G/C polymorphism in the 5′-untranslated region of the RAD51 gene in Polish women with breast cancer. Pol. J. Pathol. 56 (2005) 161-165.
51. Jakubowska, A., Narod, S.A., Goldgar, D.E., Mierzejewski, M., Masojc, B., Nej, K., Huzarska, J., Byrski, T., Górski, B. and Lubiński, J. Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 457-459.
52. Seedhouse, C., Faulkner, R., Ashraf, N., Das-Gupta, E. and Russell, N. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin. Cancer Res. 10 (2004) 2675-2680.
53. Carling, T., Imanishi, Y., Gaz, R.D. and Arnold, A. RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q: absence of somatic mutations. Clin. Endocrinol. (Oxf) 51 (1999) 403-407.
54. Kato, M., Yano, K., Matsuo, F., Saito, H., Katagiri, T., Kurumizaka, H., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., Nagawa, H., Nakamura, Y. and Miki, Y. Identification of Rad51 alteration in patients with bilateral breast cancer. J. Hum. Genet. 45 (2000) 133-137.
55. Wick, W., Petersen, I., Schmutzler, R.K., Wolfarth, B., Lenartz, D., Bierhoff, E., Hummerich, J., Muller, D.J., Stangl, A.P., Schramm, J., Wiestler, O.D. and von Deimling, A. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene 12 (1996) 973-978.
56. Gonzalez, R., Silva, J.M., Dominguez, G., Garcia, J.M., Martinez, G., Vargas, J., Provencio, M., Espana, P. and Bonilla, F. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Br. J. Cancer 81 (1999) 503-509.
57. Shen, C.Y., Yu, J.C., Lo, Y.L., Kuo, C.H., Yue, C.T., Jou, Y.S., Huang, C.S., Lung, J.C. and Wu, C.W. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res. 60 (2000) 3884-3892.
58. Balsara, B.R., Bell, D.W., Sonoda, G., De Rienzo, A., du Manoir, S., Jhanwar, S.C. and Testa, J.R. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma. Cancer Res. 59 (1999) 450-454.
59. De Rienzo, A., Balsara, B.R., Apostolou, S., Jhanwar, S.C. and Testa, J.R. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma. Oncogene 20 (2001) 6245-6249.
60. Natrajan, R., Louhelainen, J., Williams, S., Laye, J. and Knowles, M.A. High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder. Cancer Res. 63 (2003) 7657-7662.
61. Hanby, A.M., Kelsell, D.P., Potts, H.W., Gillett, C.E., Bishop, D.T., Spurr, N,K, and Barnes, D.M. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer. Int. J. Cancer 88 (2000) 204-208.
62. Johnson, S.M., Shaw, J.A. and Walker, R.A. Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2. Int. J. Cancer 98 (2002) 205-209.
63. Smith, S.A., Easton, D.F., Evans, D.G. and Ponder, B.A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet. 2 (1992) 128-131.
64. Garcia, J.M., Rodriguez, R., Dominguez, G., Silva, J.M., Provencio, M., Silva, J., Colmenarejo, A., Millan, I., Munoz, C., Salas, C., Coca, S., Espana, P. and Bonilla, F. Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer. Gut 52 (2003) 1756-1763.
65. Silva, J.M., Gonzalez, R., Provencio, M., Dominguez, G., Garcia, J.M., Gallego, I., Palacios, J., Espana, P. and Bonilla, F. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer. Breast Cancer Res. Treat. 53 (1999) 9-17.
66. Rio, P.G., Maurizis, J.C., Peffault de Latour, M., Bignon, Y.J. and Bernard-Gallon, D.J. Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. Int. J. Cancer 80 (1999) 823-826.
67. Santos, S.C., Cavalli, L.R., Cavalli, I.J., Lima, R.S., Haddad, B.R. and Ribeiro, E.M. Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil. J. Clin. Pathol. 57 (2004) 374-377.